| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |